Serif Biomedicines

Develops modified DNA therapeutics by integrating nucleic-acid chemistry, synthetic biology, delivery science and AI to enable programmable, scalable, durable, redosable DNA medicines. Targets genetically defined diseases and therapies that reprogram the immune system.
Load...
Load...
Load...
Load...
Load...
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...

Insights

Loading Insights...
Q1/2040}
Loading Insight content to display...
Loading Insights...
Q1/2040}
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...

Funding

Workforce

Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
Loading